Regional News
Breaking the Dirty Cycle: YEEDI's Self-Cleaning Mop Ushers in a New Cleaning Paradigm
SAN FRANCISCO, Aug. 5, 2025 /PRNewswire/ -- YEEDI
Recon Awarded Mega $5.85 Million Contract to Provide Upgrades Service for Large Mid-Asia Gas Field
BEIJING, Aug. 5, 2025 /PRNewswire/ -- Recon Technology Ltd. ("Recon" or "the Company"), aChina-based provider of oilfield and low-carbon energy services, announced today that one of its domestic affiliated entities has been awarded major contracts to upgrade and retrofit related automation system...
iNtRON Bio, Demonstrated Toxin-Neutralizing Effect of IMPA™ Phage Engineering Technology in Colorectal Cancer Model and Completed the US Patent Application
• Successful validation of payloaded anti-colibactin toxin phage using IMPA™ technology • Demonstrated 'Dual-target Therapeutic Strategy' by bacterial eradication and toxin neutralization • Filed the US patent application for the candidate substance and preclinical studies including PoC unde...
Court Sides with Cardiovalve in Edwards patent spat
HANGZHOU, China, Aug. 5, 2025 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. ("Venus Medtech", Stock Code: 02500.HK) recently announced a decisive legal victory for its wholly-owned subsidiary Cardiovalve Ltd. ("Cardiovalve") against Edwards Lifesciences Corporation and Edwards Lifesciences LLC. ...
Aurzen Redefines Portable Entertainment with BOOM air, a Searchlight-Style Projector Featuring Powerful Built-in Dolby Audio
The ultra-portable projector boasts a 110° integrated gimbal, Google TV, and real-time focus for effortless big-screen experiences on any surface. IRVINE, Calif., Aug. 5, 2025 /PRNewswire/ -- Aurzen, an innovator in immersive home entertainment, today redefines the portable projector category wi...
Multiplier Launches 'Beyond Borders' Series to Explore the Realities of Global Employment
The new video series features conversations with global experts and
future-of-work influencers on the challenges and opportunities of hiring,
scaling, and managing teams across borders.
NEW YORK, Aug. 5, 2025 /PRNewswire/ -- With about 74% of employers
Ascletis Completes Enrollment in U.S. Phase IIa Study for Its Small Molecule Oral GLP-1R Agonist, ASC30, in Participants with Obesity or Overweight
- 13-week U.S. Phase IIa study is evaluating the efficacy, safety and tolerability of two oral formulations of ASC30, a once-daily tablet, in 125 participants with obesity or overweight. - All 125 participants enrolled in just over one month; topline data expected in the fourth ...
RLX Technology to Report Second Quarter 2025 Financial Results on August 22, 2025
- Earnings Call Scheduled for 8:00 a.m. ET on August 22, 2025 - SHENZHEN, China, Aug. 5, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE: RLX), a leading global branded e-vapor company, today announced that it will report its unaudited financial results for the...
World Intelligent Vehicle Conference 2025 Successfully Concludes
Writing a New Chapter for the Development of Intelligent Vehicles CHONGQING, China, Aug. 5, 2025 /PRNewswire/ -- World Intelligent Vehicle Conference (WIV) 2025 successfully concluded at the Chongqing Yuelai International Conference Center onJuly 31. Hosted by Asia Digital Group, the two-day ev...
Yum China Board Welcomes New Board Member
SHANGHAI, Aug. 5, 2025 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China") (NYSE: YUMC and HKEX: 9987) announced today the appointment of Mr. Zhe (David) Wei to the Board of Directors, effectiveAugust 6, 2025. In connection with the appointment, the Board has increased the siz...
Yum China Reports Second Quarter 2025 Results
Operating Profit Increased 14% YoY; OP Margin Expanded 100 Basis Points to 10.9%, a Second-Quarter Record High Same-Store Sales Growth Turned Positive, Driven by 10th Consecutive Quarter of Same-Store Transaction Growth Diluted EPS Up 5%, or 15% Excluding Mark-to-Market and F/X Impact SHANGHAI, A...
Fapon Biopharma Announces the enrollment of the First Patient in the Phase I Clinical Trial of FP008, A First-in-Class Immunotherapy for Solid Tumors
DONGGUAN, China, Aug 5, 2025 /PRNewswire/ -- Fapon Biopharma, a biotech in developing therapeutic antibodies and fusion proteins, is delighted to announce the completion of the first patient enrollment inChina for its Phase I clinical trial of FP008 , a first-in-class immunotherapy for solid tum...
Chunghwa Telecom Reports Un-Audited Consolidated Operating Results for the Second Quarter of 2025
TAIPEI, Aug. 5, 2025 /PRNewswire/ -- Chunghwa Telecom Co., Ltd. (TAIEX: 2412, NYSE: CHT) ("Chunghwa" or "the Company") today reported its un-audited operating results for the second quarter of 2025. All figures were prepared in accordance with Taiwan-International Financial Reporting Standards ("...
WuXi XDC Achieves GMP Release of Newly Launched DP3 Facility at Wuxi Site, Scaling Further Drug Product Manufacturing Capacity
WUXI, China, Aug. 4, 2025 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, announced that the Drug Product 3 ("DP3") facility at the Wuxi site has c...
SatSure and KALRO Partner to Leverage Satellite Data for Agricultural Transformation in Kenya
BANGALORE, India, Aug. 5, 2025 /PRNewswire/ -- SatSure Analytics India Pvt. Ltd., one of the leading Earth Observation (EO) data refinery platforms, has partnered with Kenya Agricultural and Livestock Research Organisation (KALRO) to revolutionize agricultural productivity and resilience inKenya ...
METiS Technologies Closes RMB 400 Million Series D Financing to Power Beijing's Biopharmaceutical Innovation Engine
BEIJING, China, Aug. 4, 2025 /PRNewswire/ -- METiS Technologies, a global leader in AI-driven nanodelivery innovation, today announced the successful completion of itsRMB 400 million Series D financing round. The announcement was made at the Zhongguancun (Daxing) Cell and Gene Therapy Industrial ...
Innovent Receives U.S. FDA Approval for IND Application of Oral GLP-1R Agonist IBI3032
SAN FRANCISCO and SUZHOU, China, Aug. 4, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...
High-Trend International Group Announces the Reverse Split Record Date
NEW YORK, Aug. 4, 2025 /PRNewswire/ -- High-Trend International Group (the "Registrant" or the "Company") (NASDAQ: HTCO), a global ocean technology company is reporting that its board of directors (the "Board") has approved a reverse stock split (the "Reverse Stock Split") of the Company's Class ...
K-Comics Make Inroads with North American Buyers and Fans
KOCCA Hosts K-Story&Comics in America * Five-day business and exhibition event held in Los Angeles starting July 30 * 10 Korean content companies held export consultations worth $15.7 million * Strong interest from global players like Netflix, Alcon, Inklore, and Tokyopop in K-Comics * Ove...
IDEART AI Presents One‑Stop AI Studio Empowering Creators with Instant Visual Workflows
LONDON, Aug. 4, 2025 /PRNewswire/ -- ideart.ai
Week's Top Stories
Most Reposted
Agoda Launches Free Global eSIMs for VIP Diamond Members
[Picked up by 322 media titles]
2026-02-10 14:00Ascentium Acquires Clara, Expanding into the Abu Dhabi Global Market (ADGM) and Strengthening its Middle East Presence
[Picked up by 310 media titles]
2026-02-12 14:00Blackpanda Japan Announces Strategic Partnership with SoftBank to Strengthen Cyber Incident Response in Japan
[Picked up by 299 media titles]
2026-02-10 13:31Rockwell Automation Strengthens Industrial Cybersecurity with New Security Operations Center in Singapore
[Picked up by 299 media titles]
2026-02-09 10:00Carro unveils quirky generative AI ad campaign highlighting its 'Surprisingly Short' AI-enabled car-selling process
[Picked up by 296 media titles]
2026-02-11 11:00